Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06272461

Comparison of Intravenous Lidocaine vs Ketamine in Colorectal Surgery

The Effect of Intravenous Lidocaine or Ketamine on Interleukin-6 Levels in Patients Undergoing Colorectal Surgery for Cancer: A Randomized Controlled Trial

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
50 (estimated)
Sponsor
University Tunis El Manar · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Patients undergoing open colorectal surgery were randomly divided into two groups: Intravenous Lidocaine (IV-Lido) vs Intravenous Ketamine (IV-Keta). For the IV-Lido group, patients received a loading dose of Lidocaine than a continuous infusion over twenty-four hours. For the IV-Keta goup, patients received a loading dose of Ketamine than a continuous injection of Ketamine over twenty-four hours. Plasma concentrations of Interleukin-6(IL-6) were measured preoperatively before anesthetic induction and at twenty-four hour post operatively.

Detailed description

Patients undergoing open colorectal surgery with tumor resection were randomised prospectively into two groups: Intravenous Lidocaine (IV-Lido) vs Intravenous Ketamine (IV-Keta). For the IV-Lido group (n=25), patients received a loading dose of 1.5 mg/kg of Lidocaine than a continuous infusion of 1.5 mg/kg/h over twenty-four hours. For the IV-Keta goup(n=25), patients received a loading dose of 0.15mg/kg of Ketamine than a continuous injection of 0.15 mg/kg/h of Ketamine over twenty-four hours. For both groups, plasma concentrations of Interleukin-6(IL-6) were measured preoperatively before anesthetic induction and at twenty-four hour post operatively. Plasma IL-6 concentrations at each point were compared between the groups.

Conditions

Interventions

TypeNameDescription
DRUGLidocaine IVIntravenous Lidocaine Vs intravenous Ketamine in colorectal surgery for cancer
DRUGKetamine Injectable SolutionIntravenous Lidocaine Vs intravenous Ketamine in colorectal surgery for cancer

Timeline

Start date
2023-10-01
Primary completion
2026-02-10
Completion
2026-03-30
First posted
2024-02-22
Last updated
2025-11-18

Locations

1 site across 1 country: Tunisia

Source: ClinicalTrials.gov record NCT06272461. Inclusion in this directory is not an endorsement.